Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER, Aherrera JAM, de Paz-Silava SLM, Mondragon AV, Malundo AFG, Tan JJE, Tantengco OAG, Quebral EPB, Uy MNAR, Lintao RCV, Dela Rosa JGL, Mercado MEP, Avenilla KC, Poblete JB, Albay AB Jr, David-Wang AS, Alejandria MM.
Punzalan FER, et al. Among authors: de paz silava slm.
Front Immunol. 2023 Feb 28;14:1123497. doi: 10.3389/fimmu.2023.1123497. eCollection 2023.
Front Immunol. 2023.
PMID: 36926338
Free PMC article.